Our Services
Medical Information
Helpful Resources
Published on: 10/9/2026
Postherpetic itch is a persistent, sometimes intense itching that lingers in the skin where a shingles rash appeared, caused by damage the varicella-zoster virus does to sensory nerves rather than by any ongoing skin problem. It often overlaps with postherpetic neuralgia (nerve pain), and because the affected skin can also feel numb, scratching may lead to wounds without the person noticing. Most cases fade within a few weeks to several months after the rash heals, though some people experience it for a year or longer, with older adults and those who had severe rashes at higher risk. Timelines, warning signs, and treatment options differ meaningfully from person to person, so see below to understand the full picture before assuming it will simply go away.
Because itching after shingles can signal anything from healing nerves to a complication that needs prompt care, guessing is rarely the best strategy, and a free, instant symptom check can help you organize your symptoms, see which conditions match your pattern, and know whether to monitor at home or contact a clinician now.
Last reviewed for medical accuracy: 10/08/2026
Postherpetic itch is an uncomfortable, often persistent itching sensation that can occur after a shingles (herpes zoster) rash has healed. While most people associate shingles with pain or nerve sensitivity, this distinct itch can be equally bothersome. Understanding what postherpetic itch is, why it happens, and how long it may last can help you manage symptoms more effectively and know when to seek professional care.
Nerve Injury
Inflammation
Skin Changes
Central Sensitization
The duration of postherpetic itch varies widely from person to person:
Short-Term Itch (Weeks to Months)
Intermediate Duration (3–6 Months)
Long-Term Itch (6 Months to Years)
Factors influencing duration:
Postherpetic itch may present in various ways:
Keep track of:
There is no single cure-all, but several strategies can help control postherpetic itch:
While postherpetic itch is seldom life threatening, consult a doctor if you experience:
For non-urgent concerns, you might also consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Postherpetic itch can be a challenging sequel to shingles, lasting from weeks to months—or in some cases, a year or longer. Understanding its nerve-based cause and employing a combination of topical, oral, and behavioral treatments can provide relief. Maintaining good skin care, managing stress, and considering shingles vaccination are key preventive steps.
If you suspect serious complications or if symptoms significantly affect your quality of life, speak to a doctor without delay. Your healthcare provider can tailor treatments and investigate underlying issues to help you regain comfort and normal function.
(References)
* Newbold PC. Skin markers of malignancy. Arch Dermatol. 1970 Dec;102(6):680-92. PMID: 4251202.
* Shenefelt PD. Hypnosis in dermatology. Arch Dermatol. 2000 Mar;136(3):393-9. doi: 10.1001/archderm.136.3.393. PMID: 10724204.
* Rigopoulos D, Paparizos V, Katsambas A. Cutaneous markers of HIV infection. Clin Dermatol. 2004 Nov-Dec;22(6):487-98. doi: 10.1016/j.clindermatol.2004.07.007. PMID: 15596320.
* Roberts WE. Dermatologic problems of older women. Dermatol Clin. 2006 Apr;24(2):271-80, viii. doi: 10.1016/j.det.2006.01.012. PMID: 16677973.
* Oaklander AL. Neuropathic itch. Semin Cutan Med Surg. 2011 Jun;30(2):87-92. doi: 10.1016/j.sder.2011.04.006. PMID: 21767768; PMCID: PMC3139924.
* Nasseri YY, Osborne MC. Pruritus ani: diagnosis and treatment. Gastroenterol Clin North Am. 2013 Dec;42(4):801-13. doi: 10.1016/j.gtc.2013.09.002. Epub 2013 Nov 7. PMID: 24280401.
* Üçeyler N. Small fiber pathology--a culprit for many painful disorders? Pain. 2016 Feb;157 Suppl 1:S60-S66. doi: 10.1097/j.pain.0000000000000411. PMID: 26780379.
* Koshy E, Mengting L, Kumar H, Jianbo W. Epidemiology, treatment and prevention of herpes zoster: A comprehensive review. Indian J Dermatol Venereol Leprol. 2018 May-Jun;84(3):251-262. doi: 10.4103/ijdvl.IJDVL_1021_16. PMID: 29516900.
* Blauvelt A, Teixeira HD, Simpson EL, Costanzo A, De Bruin-Weller M, Barbarot S, Prajapati VH, Lio P, Hu X, Wu T, Liu J, Ladizinski B, Chu AD, Eyerich K. Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial. JAMA Dermatol. 2021 Sep 1;157(9):1047-1055. doi: 10.1001/jamadermatol.2021.3023. PMID: 34347860; PMCID: PMC8340015.
* Butler DC, Berger T, Elmariah S, Kim B, Chisolm S, Kwatra SG, Mollanazar N, Yosipovitch G. Chronic Pruritus: A Review. JAMA. 2024 Jun 25;331(24):2114-2124. doi: 10.1001/jama.2024.4899. PMID: 38809527.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.